Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:mammary tumor incidence/prevalence measurement
go back to main search page
Accession:CMO:0000946 term browser browse the term
Definition:A measurement in which the number of individuals in a study population displaying one or more tumors of the mammary gland at a point in time or developing such growths within a determined period of time, are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. A tumor is an abnormal growth of tissue resulting from uncontrolled, progressive multiplication of cells and serving no physiological function.



show annotations for term's descendants           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 0
    tumor measurement 0
      mammary tumor measurement 0
        mammary tumor incidence/prevalence measurement 0
          percentage of study population developing mammary tumors during a period of time 0
          percentage of study population displaying mammary tumors at a point in time 0
Path 2
Term Annotations click to browse term
  clinical measurement 0
    organ measurement 0
      organ lesion measurement 0
        organ tumorous lesion measurement 0
          organ tumorous lesion incidence/prevalence measurement 0
            tumor incidence/prevalence measurement 0
              mammary tumor incidence/prevalence measurement 0
                percentage of study population developing mammary tumors during a period of time 0
                percentage of study population displaying mammary tumors at a point in time 0
paths to the root